2023 Annual Meeting | C179 - Epilepsy: Surgery and Neuromodulation

Date Wednesday 04/26/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Carol M. Ulloa, MD, FAES, F�鶹��ýӳ��

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should be able to recognize how epilepsy surgery risk is overestimated, evaluate how minimally invasive epilepsy surgery options may mitigate patient surgical risk perception, and identify the surgery evaluation as a collaborative process where patients and physicians make choices based on individual risk tolerance. Participants will also develop a better understanding of neuromodulation for the treatment of epilepsy, including responsive neurostimulation and deep brain stimulation. Through thought-provoking case-based interactive panel discussion, attendees will also analyze surgical decision-making. This program complements Epilepsy: Basics and Considerations Across the Age Span: Pediatrics, Pregnancy, Elderly, and Special Populations, but covers independent topics.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Fellow, Specialist Neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:35 PM EST	Introduction	Introduction Carol M. Ulloa, MD, FAES, F�鶹��ýӳ��
03:35 PM - 04:05 PM EST	Speaker	Using Minimally Invasive Procedures to Reframe Epilepsy Surgery Consideration Patrick Landazuri, MD, F�鶹��ýӳ��
04:05 PM - 04:35 PM EST	Speaker	Neuromodulation in Epilepsy Vikram Rao, MD
04:35 PM - 05:30 PM EST	Speaker	Cases with Panel Discussion Carol M. Ulloa, MD, FAES, F�鶹��ýӳ��, Vikram Rao, MD, Patrick Landazuri, MD, F�鶹��ýӳ��, Barbara C. Jobst, MD, PhD, F�鶹��ýӳ��

Faculty Disclosures
Carol M. Ulloa, MD, FAES, F�鶹��ýӳ��	The institution of Dr. Ulloa has received research support from medtronics. An immediate family member of Dr. Ulloa has received research support from NIH.
Vikram Rao, MD	Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precisis GmbH. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iVEAcare. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace, Inc.. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. Dr. Rao has stock in Doximity, Inc. Dr. Rao has stock in Theta Neurotech. Dr. Rao has stock in Encephalogix.
Patrick Landazuri, MD, F�鶹��ýӳ��	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Barbara C. Jobst, MD, PhD, F�鶹��ýӳ��	Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.